Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Breast 1

Conditions

Neutropenia 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Leukemia 1Depression 1Breast Neoplasms 1Body Weight Changes 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Vegetables × Clear all
NCT00068458 2017-12-19

Survival TRaining for ENhancing Total Health (STRENGTH)

Duke University

Phase 2 Completed
39 enrolled
Breast

Body Weight Changes, Breast Neoplasms, Depression

NCT00947648 2014-06-13

Outpatient Neutropenic Diet Study

M.D. Anderson Cancer Center

Phase 2 Terminated
30 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡